Despite the considerable interest in the possibility that on capsaicin-sensitive sensory neurons, since in skin treated repeatedly with topical capsaicin pain was reduced ATP may function as a peripheral pain mediator, there has been little quantitative study of the pain-producing to less than 25% of that elicited on normal skin (2.1 ⍨ 0.4 compared with 9.3 ⍨ 1.5 on normal skin). Conversely, effects of ATP in humans. Here we have used iontophoresis to deliver ATP to the forearm skin of volunteers who the pain-producing effects of ATP were greatly potentiated in several models of hyperalgesia. Thus, with acute rated the magnitude of the evoked pain on a visual analogue scale. ATP consistently produced a modest capsaicin treatment when subjects exhibited touch-evoked hyperalgesia but no ongoing pain, there was a threefold burning pain, which began within 20 s of starting iontophoresis and was maintained for several minutes.
Introduction
The suggestion that ATP might have important neural actions substance acts as a neurotransmitter have slowly been proven for ATP. Thus, it is present in many neurons, and on release, is not new. Forty years ago, Pamela Holton demonstrated the release of ATP from some peripheral nerve fibres. In the it produces receptor-mediated post-synaptic effects and there are degradative mechanisms to terminate its actions (Brake intervening years, evidence of widespread and powerful neuronal actions of ATP has accumulated (Burnstock, 1997) .
and Julius, 1996) . This role as a neurotransmitter is now generally accepted in the sympathetic nervous system (for All of the classical criteria required to demonstrate that a review, see Sneddon et al., 1996) , the dorsal horn of the on the threshold dose of ATP required to elicit pain and very limited information about the nature of this pain. Therefore, spinal cord (Jahr and Jessell, 1983; Fyffe and Perl, 1984; Salter and Henry, 1985) and the medial habenula of the brain we have undertaken a quantitative study of ATP-induced pain, paying particular attention to the duration of the (Edwards et al., 1992) .
In the last decade there have been major advances in our response, the desensitization properties of the response and how the response varies in normal and hyperalgesic skin in understanding of the nature, distribution and functioning of receptors for ATP, most notably the identification of a family healthy volunteers. of ligand-gated ion channels, the P2X family. There are currently seven known members of this family, all of which have been cloned, named P2X 1-7 system (for review, see
Methods
Ralevic and Burnstock, 1998) . Studies of the distribution of Subjects these receptors have led to a resurgence of interest in the A group of 21 healthy adults (male and female, aged 21-44 possibility that ATP might have functions in addition to that years) participated in the experiments after having given of a neurotransmitter. In particular, in situ hybridization and informed consent. All subjects were familiar with the Northern blotting techniques have revealed that six out of psychophysiological techniques employed in this study. All seven members of the P2X family are located on primary protocols had been approved by the ethical committee of St sensory neurons (Kidd et al., 1995; Lewis et al., 1995; Collo Thomas' Hospital. et al., 1996) . One of these, the P2X 3 receptor, is exclusively distributed on small diameter neurons in the dorsal root ganglion that are thought to be nociceptors (Chen et al., Iontophoresis of ATP or saline Lewis et al., 1995) . An issue of considerable current
The experimental area of skin (always on the volar forearm) interest, therefore, is whether ATP might be released into was cleaned with an alcohol swab before attaching a 9 mm peripheral tissues following injury and activate nociceptors, diameter Perspex iontophoresis chamber (Moor Instruments, i.e. act as a peripheral mediator of pain. Obviously, if true, Axminster, UK) to the ventral surface of the subject's forearm this finding could lead to the development of novel classes using an adhesive disc. The chamber was then filled with of analgesic drugs, based on antagonism of ATP receptors.
the test solution, which was connected to the cathode of the Animal studies have provided considerable circumstantial iontophoretic circuit. The indifferent electrode was held in evidence for this suggestion (see Discussion). Briefly, ATP the subject's palm. The iontophoresor (Phoresor II PM 700, produces aversive nocifensive behaviour when injected IOMED, Salt Lake City, UT, USA) delivered constant currents intradermally (Bland-Ward and Humphrey, 1997; Hamilton (0.1-0.8 mA) for specific times, and ATP and saline were et al., 1999a); it can activate nociceptors in vivo, and it can iontophoresed into different experimental sites on the ventral produce strong inward currents in these neurons in vitro forearm of the subject. Each site was used for only one (Krishtal et al., 1983; Bean, 1990) . This circumstantial iontophoretic trial (except in the experiments on evidence has led to the theory that, in vivo, ATP mediates desensitization and recovery, see below). The subject was nociception via a receptor encompassing the P2X 3 subunit, blind as to which solution was being applied. In the first set located on sensory neurons (Chen et al., 1995; Kennedy and of experiments the iontophoresis was carried out over a Leff, 1995; Burnstock, 1997) .
period of 4 min. There are, however, much fewer data relating to the effects of ATP on human pain-signalling systems; only two studies have been performed. Bleehen and Keele applied, among Psychophysiological magnitude estimations of other things, ATP to blister bases raised in human volunteers induced pain (Bleehen and Keele, 1977) . They reported that even dilute During iontophoresis, the subject was required to assess the solutions (as low as 1-3 µM, 0.2 ml applied for 2 min) degree of pain they were experiencing using an electronic produced pain with a delayed onset and typically lasting for visual analogue scale (VAS), generated on a personal 30-100 s. The majority of the experiments were carried out computer. The subject was required to rate pain intensity by on one subject. In the other published study (Coutts et al., moving a computer mouse every 20 s on a scale of 0-100, 1981) ATP was injected intradermally. These authors also where 0 corresponded to no pain and 100 to the worst pain reported that ATP produced pain, but there was no information imaginable for that area of skin. The average pain rating over regarding the magnitude or duration of the pain experienced. a 4-min iontophoresis session was calculated for each subject. These two studies report conflicting information about the threshold dose required to elicit a pain response. Coutts and colleagues report that pain was only elicited with doses of Blood flow responses to iontophoresis of ATP about 250 nmol or more of ATP (deduced from their data) (Coutts et al., 1991) , whereas Bleehen and Keele found doses
and saline
The blood flow response to iontophoresis of ATP and saline of 0.2-0.6 nmol effective (Bleehen and Keele, 1977) .
In summary, early works provide conflicting information at 0.2 mA for 4 min was assessed using a laser Doppler blood flow monitor (MBF3D, Moor Instruments). The blood UK). Capsaicin solution (0.05 ml) was applied to the area of skin within the tube. After 45 min, the capsaicin solution flow directly over the iontophoresed area was monitored using a cylindrical probe fixed over the ATP or saline and rubber tubing were removed and the experimental area cleaned with alcohol. At this time-point it was established solution. Blood flow outside of the area of iontophoresis was monitored by a needle probe fitted into a hole in the Perspex, that the spontaneous pain had subsided but touch-induced pain (provoked with a cotton swab brushed lightly across the 3 mm from the outside edge of the iontophoresis chamber. Neither of the probes touched the skin but were fixed just skin) was still present. ATP and saline were iontophoresed on to the experimental area and, subsequently, to an area of above it. The output of the blood flow monitor was recorded on a Macintosh Performa 460 (Apple Computer Inc., untreated skin on the contralateral forearm. The pain response was monitored using the VAS. The current used was 0.3 mA. Cupentino, Calif., USA) using a MacLab/4e and Chart software (v3.5, AD Instruments, Castle Hill, Australia).
The subject was blind as to which solution was being iontophoresed at any one time.
Time-course of desensitization and subsequent UV irradiation recovery
The response to ATP was compared between normal skin In another set of experiments, ATP was iontophoresed and skin which had received a standard dose of UV irradiation. continuously for 12 min at one site at 0.3 mA current. Having Solar simulated radiation (SSR) from a 1000 W xenon established that the response to ATP diminishes within that arc solar stimulator (Oriel, Leatherhead, UK) was used to time-period, a second set of experiments was carried out administer a specific dose of radiation to 1 cm 2 sites on the whereby ATP was iontophoresed for an initial period of 8 subjects' forearms. About 90% of the spectrum of SSR falls min and then again for 4 min either 5, 35 or 60 min after within the UVB range (280-320 nm). Initial experiments the end of the initial iontophoresis period (i.e. each subject were carried out to establish the minimal erythema dose had two trials at the same site; an initial 8 min session at (MED) for each subject. For this purpose, six 1 cm 2 sites t ϭ 0 followed by a second 4-min iontophoresis session were exposed to increments of UV radiation (dose separation starting at t ϭ 13, 43 or 68 min).
factor ϭ α2). The MED is the dose that results in erythema that is just perceptible after 24 h, as measured using an electronic erythema meter (Dia-Stron, Andover, UK). Having
Desensitization following repeated topical
established this for each subject, two sites were then irradiated capsaicin treatment with a dose of 2 ϫ MED. At 24, 48 and 72 h following The effect of iontophoresing ATP on to skin desensitized irradiation, ATP and saline were iontophoresed for 4 min on by repeated topical application of capsaicin was assessed to normal and irradiated patches of skin (different skin areas (Carpenter and Lynn, 1981) . Nine subjects participated in for each trial). The current used in all cases was 0.3 mA. this study. An area of skin 6 ϫ 3 cm was delineated on the The pain induced by ATP or saline was monitored using the flexor/volar surface of the forearm. Capsaicin solution (1% VAS, as above. For each trial the subject was not aware of w/v) was applied using a cotton bud and the area then which experimental site was being iontophoresed or the covered with an occlusion dressing. This procedure was solution administered. repeated at 2 h intervals five times on day 1 and a further three times on day 2. Eight applications were usually sufficient to abolish the flare and pain response to capsaicin; if Solutions not, further applications were made until the response was ATP (disodium salt) was dissolved in distilled water to make abolished. Two hours after the final application, ATP and 1 or 10 mM solutions which were stored at Ϫ70°C and saline were iontophoresed on to the experimental area (using thawed on the day of use. Pilot experiments confirmed that, different sites) and an equivalent area on the contralateral for a given current, 1 or 10 mM solutions elicit the same arm. A current of 0.3 mA was used and the subject remained magnitude of pain. This finding was expected since the blind as to which solution was being tested. The pain response current at which a solution is iontophoresed determines the was monitored as before.
dose applied. Therefore, ATP solutions of either concentration were used interchangeably. Once thawed, the ATP was stored on ice until use. Commercially prepared (Steripak Ltd, Cheshire, UK) sterile saline (0.9% w/v) ampoules were used
Hyperalgesia after topical capsaicin treatment
The response to ATP was compared between normal skin as the control solution. The 1% capsaicin solution was prepared by dissolving and skin rendered hyperalgesic after acute topical application of 1% capsaicin solution. Nine subjects participated in the 0.05 g of 8-methyl-N-vanillyl-6-nonenamide (capsaicin powder; Sigma Chemicals Ltd, Poole, UK) in 0.5 ml of ethyl study. A small cylinder (1.5 cm in diameter, 1 cm in depth) was glued on to the volar surface of the subject's forearm alcohol. Once dissolved 0.5 ml of Tween 80 was added and the whole solution diluted in 4 ml of sterile saline (0.9%) to using Cyanoacrylate-gel (RS Components, Northampton, 
Data analysis and statistical analysis

Results
ATP-induced pain in normal skin
In all subjects (n ϭ 12) the iontophoresis of ATP (1 or 10 mM) caused a sensation of tingling or burning pain. The pain typically began 20 s after the onset of iontophoresis and increased in magnitude over the succeeding 120 s (Fig. 1) . A plateau level of pain was maintained over the next few minutes. When the iontophoresis was terminated, the pain for current versus magnitude of pain elicited by ATP) (Fig.  2) . The threshold current which consistently produced pain (0.2 mA) caused a rise in blood flow in the treated skin was 0.3 mA (P Ͻ 0.05, Tukey test; n ϭ 21). With the highest which started after about 30 s and had usually reached a current used (0.8 mA), the VAS rating averaged 27.8 Ϯ 0.8 plateau by the end of the 4-min period of iontophoresis over the 4-min application period. (Fig. 3 ). Blood flow measured 3 mm outside the iontophoresed Iontophoresis of saline caused almost no pain sensation area also showed a progressive, but smaller, rise. when low currents were used. Higher currents were associated Iontophoresis of saline caused a much smaller increase in with a tingling sensation or very low levels of pain. Unlike blood flow in the skin being treated, with little or no change ATP, there was no correlation between the pain produced by in blood flow in the surrounding skin. saline and current (P ϭ 0.2, one-way ANOVA for current
The areas under the blood flow curves are significantly versus magnitude of pain elicited by saline).
greater for ATP than saline for both the directly iontophoresed skin (ATP 14 956 Ϯ 3547, saline 1315 Ϯ 1722 arbitrary units/min; P Ͻ 0.01) and the skin 3 mm outside the
Changes in blood flow
Following iontophoresis of ATP (1 or 10 mM), a flare iontophoresed area (ATP 5668 Ϯ 4884, saline Ϫ76 Ϯ 360 arbitrary units; P Ͻ 0.05). occurred in the surrounding area. Iontophoresis of ATP Fig. 6 Average pain rating during 4 min of iontophoresis of ATP (1 or 10 mM) or saline on normal skin (solid bars) and on skin Fig. 4 The time-course of the pain experienced during 12 min of treated repetitively with capsaicin (striped bars) (n ϭ 9). Repeated continuous iontophoresis of ATP (1 or 10 mM) (n ϭ 6). The pain capsaicin treatment dramatically reduced the pain induced by reached a peak at 3 min and began to subside rapidly after 5 min.
ATP. It also significantly reduced the very mild degree of pain caused by saline, which is a reflection of the current-induced pain. Asterisks indicate a significant difference: *P Ͻ 0.05, **P Ͻ 0.001, paired t-test.
a complete recovery from the desensitization, we would have expected ratings similar to the initial 4 min of ATP application. As shown in Fig. 5 , average pain ratings were restored by ATP (1 or 10 mM) about 1 h after the desensitizing stimulus. At 13 and 43 min, but not 68 min, the response to ATP was still significantly less than that experienced in the initial 4 min (P Ͻ 0.05, paired t-test).
Effects of capsaicin-desensitization on ATPinduced pain
Patches of forearm skin were repeatedly treated with 1% tested with ATP (1 or 10 mM) or saline. As shown in Fig. Asterisks indicate a significant difference: *P Ͻ 0.05, 6, ATP produced a much attenuated sensation under these **P Ͻ 0.001. t-test (n ϭ 7-21).
circumstances. The average pain rating elicited on skin treated with capsaicin was reduced to less than 25% of that elicited on normal skin (2.1 Ϯ 0.4 compared with 9.3 Ϯ 1.5
Rate of desensitization and subsequent recovery on normal skin; P Ͻ 0.01, paired t-test). The effect of Figure 4 shows the time-course of the pain elicited during iontophoresing saline produced a very limited sensation of 12 min of iontophoresis of ATP (1 or 10 mM). On average, pain in normal skin (average 1.5 Ϯ 0.4), which is attributable the pain caused by ATP reached a peak at about 3 min and to the effect of the current. This too is reduced in capsaicinthen began to diminish. After 5 min, the pain caused by ATP desensitized skin (0.4 Ϯ 0.2; P Ͻ 0.05, paired t-test). had subsided to less than half its peak rating. By 10 min, However, the reduction in the pain caused by ATP is clearly the pain was one-fifth of that experienced at the peak. Figure  over and above that which can be explained by reduction in 5 shows the average degree of desensitization by pooling current-induced pain. Thus, the pain induced by iontophoresis VAS ratings into three 4-min bins (0-4, 4-8 and 8-12 min), of ATP is mediated by capsaicin-sensitive primary afferent the last of which is statistically different from the first (P Ͻ neurons. 0.05, paired t-test). In different trials, the rate of recovery from this state of desensitization was studied. An initial desensitizing stimulus lasting 8 min was applied. A test Hyperalgesia after acute topical capsaicin stimulus lasting 4 min was subsequently applied to the same site after varying intervals. If the skin remained desensitized,
treatment
In contrast to the consequences of repeated capsaicin we would have expected ratings similar to those seen after 8-12 min of iontophoresis, as above. However, if there was treatment, a single topical treatment produced a strong Fig. 7 Effect of capsaicin-induced hyperalgesia on the pain caused by iontophoresis (n ϭ 9). The average VAS rating during Fig. 8 Average VAS rating elicited by ATP (1 or 10 mM) (top) 4 min of iontophoresis of ATP is significantly greater on and saline (bottom) at 24, 48 and 72 h to skin treated with a dose capsaicin-treated skin (striped bars) than on normal skin (solid of 2 ϫ MED of UV irradiation. The potentiation of the pain bars). Asterisks indicate a significant difference: **P Ͻ 0.001, response to ATP is significant at 24 h when compared with that paired t-test.
elicited on normal skin. Asterisks indicate a significant difference: *P Ͻ 0.05, paired t-test. The trend continues at 48 h but the effect has worn off at 72 h. The pain elicited by saline is unaffected by UV irradiation.
burning pain, which waned after 40 min, and hyperalgesia to touch, which persisted for 1-2 h. We applied ATP (1 or Discussion 10 mM) to skin treated with capsaicin at a time when the There is much circumstantial evidence to suggest that ATP pain had disappeared but the hyperalgesia remained. When may function as a peripheral mediator of pain. However, no this was done, a threefold increase in the average pain previous study has quantified the magnitude and duration of rating during ATP iontophoresis (22.7 Ϯ 3.1) was observed, pain elicited by ATP or correlated the magnitude of pain compared with pre-capsaicin treatment (7.8 Ϯ 2.6) (Fig. 7) .
elicited with dose in human volunteers. In this study, we have The potentiation of ATP-induced pain by capsaicin is highly characterized the pain-producing effects of iontophoretically statistically significant (P Ͻ 0.001, paired t-test). The applied ATP. This means of delivery overcomes the potential responses to saline iontophoresis increased but this problem of rapid breakdown of injected ATP and allows increase does not reach statistical significance (P Ͼ 0.05, prolonged effects to be studied. Iontophoresis delivers the paired t-test). Even if there was some sensitization to current drug over a defined area and is quantitative, i.e. the amount it does not account for all of the potentiation seen in response delivered is proportional to the iontophoretic driving current. to ATP in capsaicin-treated skin.
Iontophoresis is also atraumatic. One limitation, however, is that the actual amount of drug delivered is not known.
UV irradiation
UV irradiation also caused hyperalgesia, but unlike that
Features of ATP-induced pain
In nearly all subjects, the pain induced by ATP increased induced by capsaicin, it evolved over many hours rather than minutes. The pain produced by iontophoresis of ATP (1 or during the initial 0-20 s of delivery, presumably as the concentration of ATP in the skin increased. The plateau level 10 mM) or saline on normal skin was compared with skin treated with a dose of 2 ϫ MED of UVB irradiation at 24, of pain produced in normal skin was modest. With the highest driving current used (0.8 mA) the maximum induced pain 48 and 72 h after UV irradiation (Fig. 8) . At 24 h, the average pain rating elicited by ATP on UV-treated skin was averaged 27.8 Ϯ 0.8 on the VAS. The pain produced by ATP was essentially abolished in skin desensitized by repeated double that elicited on normal skin, increasing from 15.3 Ϯ 4.1 to 32.7 Ϯ 4.1 (P Ͻ 0.05, paired t-test). At 48 h, capsaicin application, demonstrating that it is mediated by capsaicin-sensitive nociceptors. Which functional subgroup the mean VAS response to ATP was still greater than on untreated skin, but the difference does not reach statistical of nociceptors, if any, is activated selectively by ATP was not revealed by these experiments. However, in rodent significance. At 72 h, the mean VAS response to ATP on UV irradiated skin was further reduced and does not differ nociceptors studied electrophysiologically, ATP preferentially activated C-mechanoheat nociceptors (Hamilton et al. , significantly from the response on untreated skin. The very mild pain induced by saline iontophoresis (Fig. 8, lower  1999b) . In normal and desensitized human skin, no sensations other than pain were reported with ATP iontophoresis. The panel) was clearly not affected by UV irradiation.
notion that ATP might function as a mediator of tactile
Mechanism of ATP-induced pain
stimuli following its release from Merkel cells (Malinovsky One limitation of this study is that we cannot use potentially and Pac, 1985) is not supported by our observations here toxic analogues of ATP that are selective for the different (nor indeed by our electrophysiological experiments in P2X receptors. Therefore, we can only speculate as to the which we did not see excitation of large myelinated nature of the receptor mediating activation of nociceptors by mechanoreceptive afferents with ATP).
ATP. In animal studies, we and others have been able to use The pain-producing effects of ATP were greatly potentiated the more selective ATP analogue αβ-methylene ATP. The in hyperalgesic skin. In both UV inflammation and in nocifensive response elicited by αβ-methylene ATP in rats capsaicin-induced hyperalgesia, ATP elicited more than twice was similar to that induced by ATP in humans, with respect the expected pain. These findings are consistent with the to latency and duration, potentiation in hyperalgesic skin, and observed increase in nociceptive effects of ATP analogues dependency on capsaicin-sensitive nociceptors. αβ-methylene in animal models of hyperalgesia (Hamilton et al., 1999a) .
ATP is specific for P2X 1 and P2X 3 receptors. However, P2X 1 Our observations in human skin may help reconcile important mRNA is present in very limited amounts in the dorsal root differences that have been reported in the only other two ganglion. Therefore, in rats it appears that the activation of studies of ATP-induced pain in humans. Coutts and colleagues nociceptors by ATP analogues is mediated, at least in part, report that pain was only elicited with a minimum dose of by a receptor encompassing the P2X 3 protein. Since the 250 nmol of ATP in 50 µl (Coutts et al., 1981) , whereas features of ATP-induced pain in humans parallel those seen Bleehen and Keele found doses of 0.2-0.6 nmol in 200 µl with the selective P2X 3 analogue in rat, it seems reasonable to be effective (Bleehen and Keele, 1977) . The former study to suggest that the same conclusion might be drawn for was undertaken on normal skin, while in the latter, compounds human skin. A number of studies have been carried out to were applied to human blister bases, a condition that may elucidate the population of nociceptors which express the have sensitized nociceptors to the agonists. It is not clear P2X 3 receptor. Nociceptors can be subdivided into two what mechanism underlies the increased sensitivity to ATP. subsets according to their dependency on neurotrophins and In both the models studied here (capsaicin hyperalgesia and the presence of certain immunohistochemical markers. The UV inflammation), there is insufficient time for altered gene P2X 3 receptor is present in about 35% of dorsal root ganglion expression (for instance, upregulation of ATP receptors) to neurons (Bradbury et al., 1998) . The majority (85%) of contribute to the altered sensitivity. The responsiveness of P2X 3 -postive cells fall into the population of small diameter some P2X receptors is known to be enhanced by low pH unmyelinated nociceptors which are dependent on GDNF (Wildman et al., 1997) , but this too is unlikely to explain (glial cell line derived neurotrophic factor); these nociceptors the altered sensitivity of capsaicin-treated skin.
do not express neuropeptides and they bind the plant lectin Phosphorylation of receptor proteins appears to be a common IB4 (Bradbury et al., 1998) . They terminate with a specific event in a variety of models of hyperalgesia (Dray, 1995) distribution within the inner lamina II in the dorsal horn of and might occur in the case of P2X receptors. Whatever the the spinal cord. mechanism, our observations suggest that a modest release There is a possibility that ATP activates nociceptors of endogenous ATP would be capable of contributing to the indirectly via its degradation products. Extracellular activation of nociceptors in some persistent pain states.
endonucleotidases are responsible for cleaving ATP to produce ADP, which in turn is rapidly broken down into adenosine. Coutts and colleagues reported that subjects experienced pain with higher doses of ADP (Coutts et al.,
Desensitization phenonomen
1981). Bleehen and Keele also reported that ADP, AMP and The pain produced by ATP diminished after several minutes, adenosine produced algogenic actions on the human blister despite the provision of ATP by continuing iontophoresis.
base (Bleehen and Keele, 1977) . However, in the animal The time-course of this desensitization is similar to that seen study carried out by Bland-Ward and colleagues adenosine when ATP is injected intradermally in rats and nocifensive did not elicit the same nocifensive paw-lifting response seen behaviour is studied (Hamilton et al., 1999a) . In the present with ATP (Bland-Ward et al., 1997) . study, we have shown that recovery of the response to ATP takes over an hour in human skin. Electrophysiological studies have characterized the members of the purinoceptor family according to their desensitization properties. The P2X 3
Changes in blood flow
channel, studied in vitro, desensitizes within milliseconds.
In humans, ATP consistently elicits a modest flare response The native dorsal root ganglion ion channel, studied in vitro, (also reported by Coutts et al., 1981) . It is likely that part of appears to desensitize in a manner which is replicated by the the increased blood flow occurring directly under the ATPrecombinantly expressed heterodimer formed from P2X 3 treated skin was due to a direct effect on vascular smooth and P2X 2 . However, even in this 'slowly' desensitizing muscle. Human blood vessels contain several different types heterodimer the time-course for desensitization is within of purinoceptors, some mediating vasoconstrictor and others vasodilator responses. In human subcutaneous resistance seconds, which contrasts markedly to the situation in vivo.
adenosine compounds on the human blister base preparation. Pain
